CNS Pharmaceuticals, Inc. (CNSP) shares skyrocketed 263.46 percent to $8.40, gaining $6.09 on Monday, following the announcement of a significant private placement financing.
The stock is currently trading at $8.40, compared to its previous close of $2.31 on the Nasdaq. It opened sharply higher at $9.23 and has traded in a range of $8.84 to $10.54, with volume surging to 59,237,149 shares.
The company announced it has entered into securities purchase agreements expected to generate approximately $22.5 million in gross proceeds. The financing includes participation from institutional healthcare investors and involves the sale of common stock and pre-funded warrants. CNS plans to use the proceeds to acquire and advance new assets aligned with its updated corporate strategy.
The stock has traded between $1.90 and $34.80 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.